|
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
Recent news on
Testosterone Gel
BioSante Pharmaceuticals Announces $16.5 Million Private Placement ... - 25 May 2007 Business Wire (press release),...associated with menopause, and LibiGel ® (transdermal testosterone gel) in Phase III development for the treatment of female sexual dysfunction (FSD).
AUA: Testosterone Replacement Found Useful for Post-Prostatectomy ... - 25 May 2007 MedPage Today,Daily treatment for a year with topical 1% testosterone gel significantly minimized or eliminated hypogonadal symptoms in prostate cancer patients who had a
Testosterone Gel May Benefit Men With MS - May 14, 2007 MedPage Today,Note that this small, exploratory study suggests that a testosterone gel is safe and may potentially have benefits for cognition and brain atrophy.
Multiple Sclerosis Could Be Checked Through Testosterone Gel - May 14, 2007 MedIndia,Researchers at the University of California say they have been able to use testosterone gel to effectively slow down the progression of multiple sclerosis.
Testosterone May Help Men With MS - May 20, 2007 drkoop.com...(Ivanhoe Newswire) -- Men who have Multiple Sclerosis (MS) may get some relief from a testosterone gel. Researchers from UCLA say using the gel reduced
Market Report -- In Play (AUXL) - May 22, 2007 MSN Money...testosterone gel preparations among initially unresponsive patients prior to abandoning or considering more invasive testosterone replacement therapy."
Testosterone May Help Men With Multiple Sclerosis - May 19, 2007 eMaxHealth.com,..."Overall, the use of the testosterone gel treatment in men with MS was shown to be safe and well-tolerated," she said. "In addition, our exploratory
Scientists testify in Landis doping hearing - May 21, 2007 Radio New Zealand,...at the University of Washington , expressed doubt over Landis's test results and said they were not consistent with prolonged use of testosterone gel.
Landis to take the stand in arbitration hearing - May 19, 2007 China Post,Reaching into his jacket pocket to show a packet of the testosterone gel he used, Papp refuted both Landis theories -- saying it was easy to stay below the
Racer tells how to avoid doping suspension - May 19, 2007 Albuquerque Tribune,Reaching into his jacket pocket to show a packet of the testosterone gel he used, Papp refuted both Landis theories - saying it was easy to stay below the
Landis waits to take the stand in arbitration hearing - May 19, 2007 abc7.com,Some of Schnazer's testimony was about how testosterone gel can make one of four components that are measured in a doping test spike, while leaving the
Excessive vitamin use increases men's prostate cancer risk - May 21, 2007 Los Angeles Times,A testosterone gel slowed brain deterioration and boosted thinking ability in men with multiple sclerosis, according to a small study showing a possible new
Cyclist set to testify at hearing - May 19, 2007 Monterey County Herald,Reaching into his jacket pocket to show a packet of the testosterone gel he used, Papp refuted both Landis theories—saying it was easy to stay below the
Cyclist attempting to confirm his championship with testimony at ... - May 19, 2007 NEPA News,Reaching into his jacket pocket to show a packet of the testosterone gel he used, Papp refuted both Landis theories _ saying it was easy to stay below the
Cyclist set to testify at hearing - May 19, 2007 MLive.com,Reaching into his jacket pocket to show a packet of the testosterone gel he used, Papp refuted both Landis theories — saying it was easy to stay below the
Landis to take the stand in arbitration hearing - May 18, 2007 San Diego Union Tribune,Reaching into his jacket pocket to show a packet of the testosterone gel he used, Papp refuted both Landis theories – saying it was easy to stay below the
Cyclist attempting to confirm his championship with testimony at ... - May 19, 2007 Philadelphia Daily News,Reaching into his jacket pocket to show a packet of the testosterone gel he used, Papp refuted both Landis theories , saying it was easy to stay below the
Pro cyclist describes doping techniques in Floyd Landis hearing - May 18, 2007 Canada.com,Reaching into his jacket pocket to show a packet of the testosterone gel he used, Papp refuted both Landis theories — saing it was easy to stay below the
Landis will take a turn on hot seat at hearing today - May 19, 2007 Ventura County Star (subscription),Reaching into his jacket pocket to show a packet of the testosterone gel he used, Papp refuted both Landis theories saying it was easy to stay below the
Pro cyclist describes doping techniques in Floyd Landis hearing - May 18, 2007 570 News,Reaching into his jacket pocket to show a packet of the testosterone gel he used, Papp refuted both Landis theories - saing it was easy to stay below the
Cyclist rebuts Landis' arguments - May 18, 2007 Tucson Citizen,Reaching into his jacket pocket to show a packet of the testosterone gel he used, Papp disagreed with both theories of Landis, saying it was easy to stay
Landis still waiting to take the stand in arbitration hearing - May 19, 2007 Malaysia Star,Some of Schnaezer's testimony was about how testosterone gel can make one of four components that are measured in a doping test spike, while leaving the
Landis still waiting to take the stand in arbitration hearing - May 19, 2007 San Diego Union Tribune,Some of SchnJazer's testimony was about how testosterone gel can make one of four components that are measured in a doping test spike, while leaving the
Landis still waiting to take the stand in arbitration hearing - May 19, 2007 Canada.com,Some of SchnJazer’s testimony was about how testosterone gel can make one of four components that are measured in a doping test spike, while leaving the
Landis still waiting to take the stand - May 19, 2007 SI.comSome of SchnÊazer's testimony was about how testosterone gel can make one of four components that are measured in a doping test spike, while leaving the
After LeMond shocker, star witness to take stand: Landis - May 18, 2007 Minneapolis Star Tribune (subscription),Reaching into his pocket to show a packet of the testosterone gel he used, Papp said it was easy to stay below the threshold of a positive test with the gel
Testosterone 'helps men fight MS' - May 15, 2007 The Australian,...“One year of treatment with testosterone gel was associated with improvement in cognitive performance and a slowing of brain atrophy (deterioration),� the
Testosterone protects brain in men with MS - May 15, 2007 New Scientist (subscription),After this initial half-year of observation, the men began applying a testosterone gel, containing 100 milligrams of the hormone, to their skin on a daily
Testosterone may help men with multiple sclerosis - May 15, 2007 HULIQ,..."Overall, the use of the testosterone gel treatment in men with MS was shown to be safe and well tolerated," she said. "In addition, our exploratory
Testosterone can help men battle multiple sclerosis: study - May 15, 2007 Turkish Press,..."One year of treatment with testosterone gel was associated with improvement in cognitive performance and a slowing of brain atrophy (deterioration)," the
With Landis on the sideline, experts make his case - May 23, 2007 Longview Daily News,He testified that claims made last week by pro cyclist Joe Papp, who said testosterone gel would help with recovery in a multistage cycling race,
Small study finds testosterone helps MS patients - May 14, 2007 Reuters India,WASHINGTON (Reuters) - A testosterone gel slowed brain deterioration and boosted thinking ability in men with multiple sclerosis, according to a small study
Study finds testosterone helps MS patients - May 14, 2007 Independent Online,Washington - A testosterone gel slowed brain deterioration and boosted thinking ability in men with multiple sclerosis, according to a small study showing a
Study finds testosterone helps MS patients - May 14, 2007 ReutersWASHINGTON, May 14 (Reuters) - A testosterone gel slowed brain deterioration and boosted thinking ability in men with multiple sclerosis, according to a
Possible neuroprotective effect of testosterone treatment in men - May 20, 2007 News-Medical.net,..."One year of treatment with testosterone gel was associated with improvement in cognitive performance and a slowing of brain atrophy [deterioration]," the
BioSante Pharmaceuticals Announces Issuance of New Patent Covering ... - Apr 10, 2007 Genetic Engineering News (press release),...menopause and LibiGel(R) (testosterone gel), which recently moved into Phase III clinical development for the treatment of female sexual dysfunction.
BioSante Pharmaceuticals Announces Issuance of New Patent Covering ... - Apr 10, 2007 Business Wire (press release),BioSante’s newly approved treatment for moderate to severe vasomotor symptoms associated with menopause and LibiGel ® (testosterone gel), which recently
Testosterone-based cream may help prevent Alzheimer's - Apr 2, 2007 Andhra Cafe,Rubbing a testosterone gel into the skin increased their energy levels and lifted their mood. However the gel did not appear to improve memory or other
Auxilium Pharmaceuticals to Present at the 32nd Annual Deutsche ... - Apr 24, 2007 PharmaLive.com (press release),Auxilium markets Testim(R) 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 190-person sales and marketing team.
Auxilium Pharmaceuticals to Present at the 32nd Annual Deutsche ... - Apr 24, 2007 PR Newswire (press release),Auxilium markets Testim(R) 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 190-person sales and marketing team.
Bayer Schering Pharma Presents Innovations in Men's Healthcare at ... - Mar 29, 2007 Drug Newswire (press release),Results after 6 Months Treatment with Testosterone Gel (Testogel), Symposium presentation at the 22nd Annual European Association of Urology (EAU), 2007
A hormonal knife that fights age - Apr 5, 2007 7DAYS,The local application of testosterone gel is very effective against wrinkles and cellulite,� says Doctor Hugo. The newest tool in modern anti-aging hormonal
Auxilium Pharmaceuticals to Announce First Quarter 2007 Results ... - Apr 10, 2007 PharmaLive.com (press release),Auxilium markets Testim(R) 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 190-person sales and marketing team.
BioSante Pharmaceuticals Receives Milestone Payment from Bradley ... - 27 Mar 2007 Business Wire (press release),...associated with menopause, and LibiGel ® (transdermal testosterone gel) in Phase III development for the treatment of female sexual dysfunction (FSD).
Zacks Bull and Bear of the Day Highlights: CRA International ... - Mar 26, 2007 Business Wire (press release),The company’s only approved product is Testim, a 1% testosterone gel indicated for the treatment of hypogonadism. We are concerned that the termination of
BioSante Pharmaceuticals Reports Product Development Highlights ... - Mar 9, 2007 Business Wire (press release),...“We also are very pleased to have begun the Phase III clinical program for our transdermal testosterone gel, LibiGel ® as a therapy for female sexual
BioSante Pharmaceuticals to Present at Upcoming Conferences - Mar 8, 2007 Business Wire (press release),...associated with menopause, and LibiGel ® (transdermal testosterone gel) in Phase III development for the treatment of female sexual dysfunction (FSD).
BioSante Pharmaceuticals to Present at Upcoming Conferences - Mar 8, 2007 PharmaLive.com (press release),...indicated for the treatment of moderate-to-severe vasomotor symptoms associated with menopause, and LibiGel(R) (transdermal testosterone gel) in Phase
Bayer Schering Pharma presents innovations in men's healthcare - Mar 23, 2007 Prdomain Business Register (press release),Results after 6 Months Treatment with Testosterone Gel (Testogel), Symposium presentation at the 22nd Annual European Association of Urology (EAU), 2007
Street Pulse: BioSante betting on boomers - Mar 13, 2007 Science Daily (press release)But (BioSante's testosterone gel for female sexual dysfunction) LibiGel has the potential to be a much, much bigger product in a much, much bigger market.
Effects of Testosterone Supplementation on Whole Body and Regional ... - Mar 6, 2007 Journal of Clinical Endocrinology and Metabolism,...antiretroviral regimen, and HIV RNA less than 10000 copies per milliliter were randomized to receive 10 g testosterone gel or placebo daily for 24 wk.
Wed: BioSante: All potential for now - Mar 8, 2007 Globes,It is also developing LibiGel, a transdermal bio-identical testosterone gel for the treatment of female sexual dysfunction, as well anti cancer treatments
Ipsen's earnings slips but prospects for 2007 are sound - Mar 20, 2007 Pharma Times (subscription),...to the anti-wrinkle treatment Reloxin/Dysport (botulinum toxin type A) and a 7.3 million-euro impairment charge relating to the testosterone gel Testim.
Auxilium Pharmaceuticals to Present at the Cowen and Company 27th ... - Mar 8, 2007 PharmaLive.com (press release),Auxilium markets Testim(R) 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 190-person sales and marketing team.
BioSante Pharmaceuticals to Present LibiGel ® at International ... - Feb 21, 2007 Business Wire (press release),...the initiation of a Phase III safety and efficacy study of LibiGel ® (transdermal testosterone gel) in the treatment of female sexual dysfunction (FSD).
BioSante Pharmaceuticals Announces Presentation/Webcast at the BIO ... - Feb 12, 2007 Nanotechnology News (press release)...indicated for the treatment of moderate-to-severe vasomotor symptoms associated with menopause, and LibiGel® (transdermal testosterone gel),
BioSante Pharmaceuticals Announces Notice of Allowance of Elestrin ... - Feb 7, 2007 Business Wire (press release),...indicated for the treatment of moderate-to-severe vasomotor symptoms associated with menopause, and LibiGel ® (transdermal testosterone gel) for the
BioSante Pharmaceuticals Announces Positive Bird Flu Results Using ... - Jan 31, 2007 PipelineReview.com (press release),...symptoms associated with menopause, and LibiGel® (transdermal testosterone gel) in development for the treatment of female sexual dysfunction (FSD).
Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full ... - Feb 15, 2007 Yahoo! News (press release)Auxilium markets Testim® 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 190-person sales and marketing team.
Male Menopause Can Be 'Devastating' - Feb 13, 2007 abc7news.com,Another method is a testosterone gel rubbed on the torso every day. The effect can be dramatic. Ira Sharlip, MD: "An increase in a sense of wellbeing,
Paladin Reports Record 2006 Fourth Quarter and Year End Results - Feb 15, 2007 PharmaLive.com (press release),Paladin entered into an exclusive Canadian distribution agreement with Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) to market Testim®, a testosterone gel
TO THE POINT - Feb 15, 2007 Investor's Business Daily (subscription)It said strong sales for its topical testosterone gel Testim helped it beat views. It projected '07 sales of $88 mil-$92 mil, above views of $87.9 mil.
Auxilium Posts 4Q Loss, Besting Street - Feb 15, 2007 Houston Chronicle,...loss that was smaller than what Wall Street expected as the biotech drug maker improved margins on strong sales of its topical testosterone gel Testim.
Auxilium Pharmaceuticals to Present at the Roth Capital Partners ... - Feb 13, 2007 PharmaLive.com (press release),Auxilium markets Testim(R) 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 180-person sales and marketing team.
Auxilium Pharmaceuticals to Present at the Roth Capital Partners ... - Feb 13, 2007 Yahoo! News (press release)Auxilium markets Testim® 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 180-person sales and marketing team.
Roth 2007 OC Conference Presenter Profiles - Feb 16, 2007 American Digital Networks (press release),Auxilium markets Testim(R) 1%, its topical testosterone gel, for the treatment of hypogonadism through its approximately 180-person sales and marketing
Stephen M. Simes, President and CEO of BioSante Pharmaceuticals ... - 18 Jan 2007 Business Wire (press release),In addition, we have initiated a Phase III clinical trial of LibiGel®, our testosterone gel, for the treatment of female sexual dysfunction,
Ban targets deals with new generic drug rivals Senate proposal says - 18 Jan 2007 Winston-Salem Journal (subscription),...a rival to its Provigil sleep-disorder pill until 2012, and a Solvay SA agreement that would keep a generic testosterone gel off the market until 2015.
Thursday's Health Winners & Losers - 18 Jan 2007 TheStreet.comResults from earlier trials on the company's LibiGel transdermal testosterone gel were positive. Shares gained 4.5% to $2.80.
BioSante Boosted on Trial Plan - 18 Jan 2007 TheStreet.comPrevious studies of the transdermal testosterone gel, called LibiGel, showed a significant increase in "satisfying sexual events" in surgically menopausal
BioSante Pharmaceuticals Initiates Phase III Study of LibiGel ... - Dec 28, 2006 PharmaLive.com (press release),...it has initiated a Phase III safety and efficacy trial of LibiGel(R) (transdermal testosterone gel) in the treatment of female sexual dysfunction (FSD).
Antares ATD(TM) Formulation Enters Phase III Study - Jan 2, 2007 American Digital Networks (press release),Our Advanced Transdermal Delivery (ATD(TM)) formulation of testosterone gel is the second of our formulated products for women's health to enter Phase III
Thu: A fair price for Allot - Jan 8, 2007 Globes,Phase III clinical trials of another of its drugs, LibiGel, a transdermal bio-identical testosterone gel for the treatment of female sexual dysfunction.
Prospects Are Good, But Hurdles Remain for BioSante Pharmaceuticals - Jan 5, 2007 Seeking Alpha,In addition, the company announced that it is proceeding to Phase III clinical trials of another drug, LibiGel, a transdermal bio-identical testosterone gel
BioSante tests female sex-dysfunction gel - Dec 28, 2006 United Press InternationalThe company said it is testing the transdermal testosterone gel in a six-month, placebo-controlled study in roughly 360 surgically menopausal women.
Market Report -- In Play (AIS) - Jan 17, 2007 MSN Money...has initiated a Phase III safety and efficacy trial of Antares' transdermal testosterone gel (currently called LibiGel) for the treatment of FSD.
This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional
|